Results 191 to 200 of about 16,210 (237)
Some of the next articles are maybe not open access.
Journal of Medicinal Chemistry, 2007
The neurohypophyseal peptides arginine vasopressin (AVP) and oxytocin (OT) mediate a wide variety of peripheral and central physiological and behavioral effects by acting on four different G-protein coupled receptors, termed V1a (vascular), V1b ...
A. Peña +9 more
semanticscholar +1 more source
The neurohypophyseal peptides arginine vasopressin (AVP) and oxytocin (OT) mediate a wide variety of peripheral and central physiological and behavioral effects by acting on four different G-protein coupled receptors, termed V1a (vascular), V1b ...
A. Peña +9 more
semanticscholar +1 more source
Haemostasis, 1990
1-Deamino-8-D-arginine vasopressin (DDAVP) was administered to 3 patients with spontaneous factor VIII inhibitors. In 2 patients with baseline factor VIII levels above 1%, a marked increase of factor VIII activity after DDAVP infusion could be observed ...
M. Muhm +8 more
semanticscholar +1 more source
1-Deamino-8-D-arginine vasopressin (DDAVP) was administered to 3 patients with spontaneous factor VIII inhibitors. In 2 patients with baseline factor VIII levels above 1%, a marked increase of factor VIII activity after DDAVP infusion could be observed ...
M. Muhm +8 more
semanticscholar +1 more source
Clinical Pharmacology and Therapeutics, 1981
The response to 1-deamino-8-D-arginine vasopressin (DDAVP), an intranasally administered analogue of vasopressin, was investigated in children and adults with central diabetes insipidus. To assess the action of DDAVP on the distal nephron, cyclic adenosine monophosphate (cAMP) excretion was assayed in urine collected 4 hr before and during four ...
Piers R. Blackett +3 more
openaire +3 more sources
The response to 1-deamino-8-D-arginine vasopressin (DDAVP), an intranasally administered analogue of vasopressin, was investigated in children and adults with central diabetes insipidus. To assess the action of DDAVP on the distal nephron, cyclic adenosine monophosphate (cAMP) excretion was assayed in urine collected 4 hr before and during four ...
Piers R. Blackett +3 more
openaire +3 more sources
Cellular and Molecular Neurobiology, 1988
1. Anterolateral cut (ALC) of the medial basal hypothalamus (MBH) in rats produces an elevation of plasma catecholamine levels, especially of norepinephrine (NE), in unstressed animals and a more pronounced rise of plasma NE levels in response to immobilization (IMO).
Lichardus B +4 more
openaire +3 more sources
1. Anterolateral cut (ALC) of the medial basal hypothalamus (MBH) in rats produces an elevation of plasma catecholamine levels, especially of norepinephrine (NE), in unstressed animals and a more pronounced rise of plasma NE levels in response to immobilization (IMO).
Lichardus B +4 more
openaire +3 more sources
Hormone Research, 1992
The effect of 1-deamino-8-D-arginine vasopressin (DDAVP) on mean arterial pressure, pulse rate (PR), plasma renin activity (PRA), plasma factor VIIIc and von Willebrand factor were studied in a case of persistent lithium-induced nephrogenic diabetes ...
C. Hober +4 more
semanticscholar +1 more source
The effect of 1-deamino-8-D-arginine vasopressin (DDAVP) on mean arterial pressure, pulse rate (PR), plasma renin activity (PRA), plasma factor VIIIc and von Willebrand factor were studied in a case of persistent lithium-induced nephrogenic diabetes ...
C. Hober +4 more
semanticscholar +1 more source
Desmopressin Acetate (1-Deamino-8-D-arginine vasopressin, DDAVP) Response Test
1989Exogenously administered desmopressin acetate (1-deamino-S-D-arginine vasopressin, DDAVP) fails to lessen the diuresis in either congenital or acquired nephrogenic diabetes insipidus. These disorders are characterised by renal tubular end-organ resistance to vasopressin, thus differentiating them from hypothalamic/pituitary diabetes insipidus, in which
P. T. Lascelles, D. Donaldson
openaire +2 more sources
La Ricerca in Clinica e in Laboratorio, 1984
A woman with multicentric reticulohistiocytosis, having symptoms including bleeding and a borderline level of factor VIII, was given an i.v. infusion of DDAVP as a pharmacological test to evaluate the release of factor VIII-related properties from storage sites.
Ugo Taddeo +3 more
openaire +3 more sources
A woman with multicentric reticulohistiocytosis, having symptoms including bleeding and a borderline level of factor VIII, was given an i.v. infusion of DDAVP as a pharmacological test to evaluate the release of factor VIII-related properties from storage sites.
Ugo Taddeo +3 more
openaire +3 more sources
1-Deamino-8-<i>D</i>-Arginine Vasopressin as a Therapy for the Bleeding Diathesis of Renal Failure
American Journal of Nephrology, 1984The treatment of the bleeding diathesis of renal failure remains unsatisfactory. 1-Deamino-8-D-arginine vasopressin (DDAVP) has recently been shown to shorten the prolonged bleeding time of renal failure and may as a result diminish the risk of clinical hemorrhage. We describe 2 cases where DDAVP was used successfully in the management of hemorrhage in
A.J. Watson, J.A.B. Keogh
openaire +3 more sources
Effect of Two-Week Infusion of Deamino <i>D</i><i>-</i>Arginine Vasopressin in Rats
Hormone Research, 1987Our purpose was to investigate a method of prolonged desmopressin (DDAVP) infusion in a free roaming rat to better understand the SIADH (syndrome of inappropriate antidiuretic hormone secretion) syndrome in man. DDAVP was infused for 2 weeks from implanted self-powered osmotic minipumps.
Hans Mokry +3 more
openaire +3 more sources
Journal of Urology, 1994
A case of familial central diabetes insipidus and dilatation of the urinary tract is reported. Administration of desmopressin for 1 year improved urinary tract dilatation with a concomitant reduction in urine volume. Urinary cyclic adenosine monophosphate and prostaglandin E2 excretion increased after treatment.
Yoshio Aso +5 more
openaire +3 more sources
A case of familial central diabetes insipidus and dilatation of the urinary tract is reported. Administration of desmopressin for 1 year improved urinary tract dilatation with a concomitant reduction in urine volume. Urinary cyclic adenosine monophosphate and prostaglandin E2 excretion increased after treatment.
Yoshio Aso +5 more
openaire +3 more sources